Clinical Trials Directory

Trials / Unknown

UnknownNCT02154854

Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE)

Effect of Advagraf on Arterial Stiffness and on Vascular Fibrosis Plasma Markers on de Novo Renal Transplant Patients

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
104 (estimated)
Sponsor
University Hospital, Tours · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare parallel-group effects between 4 months and 12 months post-transplantation 2 values of target residual concentrations of Advagraf on vascular parameters in de novo renal transplant patients.

Conditions

Interventions

TypeNameDescription
DRUGTacrolimus targeted half-dose
DRUGTacrolimus targeted plain dose

Timeline

Start date
2013-07-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2014-06-03
Last updated
2014-06-03

Locations

11 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02154854. Inclusion in this directory is not an endorsement.